Infliximab induces clonal expansion of γδ-T cells in Crohn's disease: a predictor of lymphoma risk?
<h4>Background</h4>Concominant with the widespread use of combined immunotherapy in the management of Crohn's disease (CD), the incidence of hepato-splenic gamma-delta (γδ)-T cell lymphoma has increased sharply in CD patients. Malignant transformation of lymphocytes is believed to b...
Guardado en:
Autores principales: | Jens Kelsen, Anders Dige, Heinrich Schwindt, Francesco D'Amore, Finn S Pedersen, Jørgen Agnholt, Lisbet A Christensen, Jens F Dahlerup, Christian L Hvas |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9513996591934d85848070cc69d43a23 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Maintenance treatment with infliximab for the management of Crohn&rsquo;s disease in adults
por: Renato Caviglia, et al.
Publicado: (2009) -
Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
por: Matsumoto S, et al.
Publicado: (2018) -
Infliximab en el tratamiento de la enfermedad de Crohn: Estudio preliminar
por: Gellona V,José, et al.
Publicado: (2006) -
Monocytes from infliximab-resistant patients with Crohn’s disease exhibit a disordered cytokine profile
por: Federica Gaiani, et al.
Publicado: (2020) -
Clonal selection in the human Vδ1 T cell repertoire indicates γδ TCR-dependent adaptive immune surveillance
por: Martin S. Davey, et al.
Publicado: (2017)